Expert Backs Medtronic's IP Pricing In $1.36B Tax Court Trial

By Natalie Olivo · June 16, 2021, 7:49 PM EDT

Medtronic's patent licensing arrangement with a competitor is a valid comparison when determining intercompany royalty rates, an intellectual property and economics expert testified Wednesday during the corporation's $1.36 billion transfer pricing...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login